SCHEMBL2975742

SCHEMBL2975742

CCCC1=CCc2cc(Br)ccc21

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PNMT P11086 5/20 0.38
ADRA2A P08913 1/20 0.38
ADRA2B P18089 1/20 0.38
ADRA2C P18825 1/20 0.38
HTR7 P34969 1/20 0.36
METAP1 P53582 2/20 0.34
TDP2 O95551 1/20 0.33
PARP10 Q53GL7 1/20 0.33
PARP11 Q9NR21 1/20 0.33
NPC1 O15118 1/20 0.33
GAA P10253 1/20 0.33
NFKB1 P19838 1/20 0.33
RAB9A P51151 1/20 0.33
NFKB2 Q00653 1/20 0.33
RELA Q04206 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
SRD5A1 P18405 2/20 0.33
SRD5A2 P31213 1/20 0.33
NQO2 P16083 1/20 0.32
MTNR1A P48039 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2963953 0.90 NPC1 (0.40) PNMTADRA2AADRA2BADRA2CHTR7
SCHEMBL2958345 0.89 SMN1; SMN2 (0.36) PNMTADRA2AADRA2BADRA2CHTR7
SCHEMBL2972942 0.87 NPC1 (0.35) PNMTADRA2AADRA2BADRA2CHTR7
SCHEMBL2959807 0.87 NPC1 (0.35) PNMTADRA2AADRA2BADRA2CHTR7
SCHEMBL2964016 0.87 NPC1 (0.35) PNMTADRA2AADRA2BADRA2CHTR7
SCHEMBL2962611 0.87 NPC1 (0.35) PNMTADRA2AADRA2BADRA2CHTR7
SCHEMBL2964449 0.87 NPC1 (0.35) PNMTADRA2AADRA2BADRA2CHTR7
SCHEMBL2963718 0.86 HTR7 (0.45) PNMTADRA2AADRA2BADRA2CHTR7
SCHEMBL2959482 0.86 MPO (0.42) PNMTADRA2AADRA2BADRA2CMETAP1
SCHEMBL17362233 0.79 METAP1 (0.36) PNMTADRA2AADRA2BADRA2CHTR7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7763562-B2 Heteroatom bridged metallocene compounds for olefin polymerization EXXONMOBIL CHEMICAL PATENTS INC. (US) 2010-07-27 US disclosed
US-20070135597-A1 Heteroatom bridged metallocene compounds for olefin polymerization EXXONMOBIL CHEMICAL PATENTS INC. 2007-06-14 US disclosed
WO-2006065809-A2 HETEROATOM BRIDGED METALLOCENE COMPOUNDS FOR OLEFIN POLYMERIZATION EXXONMOBIL CHEMICAL PATENTS INC. (US) 2006-06-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070135597-A1 Heteroatom bridged metallocene compounds for olefin polymerization AP2M1, AP1M1, PYM1 PNMT 2021/4885ADRA2A 2587/4885ADRA2B 2498/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.